These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23590575)

  • 1. Detection of epidermal growth factor receptor mutations in formalin fixed paraffin embedded biopsies in Malaysian non-small cell lung cancer patients.
    Shi Yeen TN; Pathmanathan R; Shiran MS; Ahmad Zaid FA; Cheah YK
    J Biomed Sci; 2013 Apr; 20(1):22. PubMed ID: 23590575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
    Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
    BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
    Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
    Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution melting analysis for epidermal growth factor receptor mutations in formalin-fixed paraffin-embedded tissue and plasma free DNA from non-small cell lung cancer patients.
    Jing CW; Wang Z; Cao HX; Ma R; Wu JZ
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6619-23. PubMed ID: 24377577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
    Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
    BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.
    Miyamae Y; Shimizu K; Mitani Y; Araki T; Kawai Y; Baba M; Kakegawa S; Sugano M; Kaira K; Lezhava A; Hayashizaki Y; Yamamoto K; Takeyoshi I
    J Mol Diagn; 2010 Mar; 12(2):257-64. PubMed ID: 20093389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital PCR detection of EGFR somatic mutations in non-small-cell lung cancer formalin fixed paraffin embedded samples.
    Carvalho TM; Dourado RM; Nakatani SM; Barros Duarte CA; Ioshii SO; Riediger IN; Tuon FF; Winter Boldt AB
    Mol Cell Probes; 2021 Aug; 58():101745. PubMed ID: 34089806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
    O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S
    BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two methods to extract DNA from formalin-fixed, paraffin-embedded tissues and their impact on EGFR mutation detection in non-small cell lung carcinoma.
    Hu YC; Zhang Q; Huang YH; Liu YF; Chen HL
    Asian Pac J Cancer Prev; 2014; 15(6):2733-7. PubMed ID: 24761893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific PCR method for identification of EGFR mutations in non-small cell lung cancer: formalin-fixed paraffin-embedded tissue versus fresh tissue.
    Suciu BA; Pap Z; Dénes L; Brînzaniuc K; Copotoiu C; Pávai Z
    Rom J Morphol Embryol; 2016; 57(2):495-500. PubMed ID: 27516024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of In-House Limit of Detection of Cell Number for PCR Based EGFR Mutations Detection in Small Biopsies of Non-Small Cell Lung Cancer.
    Xie J; Rui W; Chen X; Shen X; Zhang L; Gu Y; Dong L
    Ann Clin Lab Sci; 2020 Jul; 50(4):551-556. PubMed ID: 32826255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
    Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
    Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry.
    Mraihi Z; Ben Amar J; Bouacha H; Rammeh S; Hila L
    BMC Pulm Med; 2018 Aug; 18(1):132. PubMed ID: 30092812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting.
    Goto K; Satouchi M; Ishii G; Nishio K; Hagiwara K; Mitsudomi T; Whiteley J; Donald E; McCormack R; Todo T
    Ann Oncol; 2012 Nov; 23(11):2914-2919. PubMed ID: 22776705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of direct sequencing and ARMS assay performance in EGFR mutation analysis of non-small cell lung cancer patients].
    Li C; Wu J; Wang Z; Feng J
    Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):606-11. PubMed ID: 25130967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
    Jänne PA; Borras AM; Kuang Y; Rogers AM; Joshi VA; Liyanage H; Lindeman N; Lee JC; Halmos B; Maher EA; Distel RJ; Meyerson M; Johnson BE
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):751-8. PubMed ID: 16467085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of EGFR somatic mutations in non-small cell lung cancer (NSCLC) using a novel mutant-enriched liquidchip (MEL) technology.
    Zhang L; Yang H; Zhao Y; Liu W; Wu S; He J; Luo X; Zhu Z; Xu J; Zhou Q; Ren-Heidenreich L
    Curr Drug Metab; 2012 Sep; 13(7):1007-11. PubMed ID: 22591345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods.
    Martínez-Carretero C; Pascual FI; Rus A; Bernardo I
    Clin Chem Lab Med; 2017 Oct; 55(12):1970-1978. PubMed ID: 28432840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.